Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03291782 · ClinicalTrials.gov registry record · Phase 1
D-0120 Safety and PK/PD, Food Effect Study in Healthy Volunteers
A Phase 1 study, sponsored by InventisBio Co..
- Completed
- Registry status
- Phase 1
- Development phase
- 39
- Enrollment target
NCT03291782 is a Phase 1 study that has completed, run by InventisBio Co.. The registered enrollment target is 39 participants.
The verdict
NCT03291782, a Phase 1 study, has completed, sponsored by InventisBio Co..
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 39 participants
- Enrollment target
Study Summary
This initial clinical study in the US will be a randomized, double-blind, placebo-controlled, single-dose, dose-escalation, and sequential cohort study to evaluate the safety, tolerability, PK and PD of D-0120-NA in fasting, healthy volunteers (HVs). In food effect cohort, subjects will each receive 2 doses of D-0120-NA in an open-label manner; once in the fasted state and once in the fed state.
Interventions
- DRUG D-0120
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2017-09-13 |
| Est. Completion | 2018-08-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03291782
The ClinicalTrials.gov registry entry for NCT03291782 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is InventisBio Co., which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which D-0120 is the first listed.
NCT03291782 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03291782 about?
NCT03291782 is a clinical study titled "D-0120 Safety and PK/PD, Food Effect Study in Healthy Volunteers". This initial clinical study in the US will be a randomized, double-blind, placebo-controlled, single-dose, dose-escalation, and sequential cohort study to evaluate the safety, tolerability, PK and PD of D-0120-NA in fasting, healthy volunteers (HVs). In food effect cohort, subjects will each receiv...
What is the current status of trial NCT03291782?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 39 participants. The study started on 2017-09-13. Estimated completion is 2018-08-06.
What interventions are being tested in trial NCT03291782?
The interventions under investigation include: D-0120 (DRUG).
Who is sponsoring clinical trial NCT03291782?
This trial is sponsored by InventisBio Co., which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.